Search research articles
Contact Us
Filters
Showing results (61-70 of 602) with videos related to
Page
of 61
Sort By:
Molecular Cancer Research : MCR
|
August 10, 2013
Cancer gene discovery: exploiting insertional mutagenesis
Marco Ranzani, Stefano Annunziato, David J Adams, et al.
Plos Genetics
|
March 15, 2019
Collateral damage and CRISPR genome editing
Mark Thomas, Gaetan Burgio, David J Adams, et al.
ACS Chemical Biology
|
October 9, 2015
A Distinct Functional Site in Ω-Neurotoxins: Novel Antagonists of Nicotinic Acetylcholine Receptors from Snake Venom
Varuna Hassan-Puttaswamy, David J Adams, R Manjunatha Kini
Current Opinion in Genetics & Development
|
January 11, 2021
The use of CRISPR/Cas9-based gene editing strategies to explore cancer gene function in mice
Louise van der Weyden, Jos Jonkers, David J Adams
Current Opinion in Genetics & Development
|
March 16, 2021
Editorial overview: The most difficult of years in cancer research
David J Adams, Marcin Imielinski, C Daniela Robles-Espinoza
Nature Genetics
|
April 16, 2025
Desmosome mutations in keratinocytes fuel melanoma development
Patricia A Possik, Kerrie L Marie, David J Adams
Genome Biology
|
March 25, 2021
Unraveling the cartography of the cancer ecosystem
Roy Rabbie, Doreen Lau, Richard M White, et al.
Nucleic Acids Research
|
August 7, 2010
Slingshot: a PiggyBac based transposon system for tamoxifen-inducible 'self-inactivating' insertional mutagenesis
Jun Kong, Feng Wang, James D Brenton, et al.
Molecular Pharmacology
|
October 7, 2015
Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors
Shiva N Kompella, Hartmut Cuny, Andrew Hung, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
July 10, 2012
Next-generation sequencing of experimental mouse strains
Binnaz Yalcin, David J Adams, Jonathan Flint, et al.
Page
of 61
Search research articles
Search
Showing results (61-70 of 602) with videos related to
Sort By:
Page
of 61
Molecular Cancer Research : MCR
|
August 10, 2013
Cancer gene discovery: exploiting insertional mutagenesis
Marco Ranzani, Stefano Annunziato, David J Adams, et al.
Plos Genetics
|
March 15, 2019
Collateral damage and CRISPR genome editing
Mark Thomas, Gaetan Burgio, David J Adams, et al.
ACS Chemical Biology
|
October 9, 2015
A Distinct Functional Site in Ω-Neurotoxins: Novel Antagonists of Nicotinic Acetylcholine Receptors from Snake Venom
Varuna Hassan-Puttaswamy, David J Adams, R Manjunatha Kini
Current Opinion in Genetics & Development
|
January 11, 2021
The use of CRISPR/Cas9-based gene editing strategies to explore cancer gene function in mice
Louise van der Weyden, Jos Jonkers, David J Adams
Current Opinion in Genetics & Development
|
March 16, 2021
Editorial overview: The most difficult of years in cancer research
David J Adams, Marcin Imielinski, C Daniela Robles-Espinoza
Nature Genetics
|
April 16, 2025
Desmosome mutations in keratinocytes fuel melanoma development
Patricia A Possik, Kerrie L Marie, David J Adams
Genome Biology
|
March 25, 2021
Unraveling the cartography of the cancer ecosystem
Roy Rabbie, Doreen Lau, Richard M White, et al.
Nucleic Acids Research
|
August 7, 2010
Slingshot: a PiggyBac based transposon system for tamoxifen-inducible 'self-inactivating' insertional mutagenesis
Jun Kong, Feng Wang, James D Brenton, et al.
Molecular Pharmacology
|
October 7, 2015
Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors
Shiva N Kompella, Hartmut Cuny, Andrew Hung, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
July 10, 2012
Next-generation sequencing of experimental mouse strains
Binnaz Yalcin, David J Adams, Jonathan Flint, et al.
Page
of 61